Profile picture

Doctor Rodrigo Brandao

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)
Follow
Logo ESC

Contributor content

NT-proBNP response to intermittent levosimendan and clinical outcomes in advanced heart failure
Presentation
NT-proBNP response to intermittent levosimendan and clinical outcomes in advanced heart failure
Sustained clinical stability and quality of life with intermittent levosimendan: a real-world experience of over 550 administrations
Presentation
Sustained clinical stability and quality of life with intermittent levosimendan: a real-world experience of over 550 administrations
Mortality predictors and prognostic implications of intermittent levosimendan therapy in advanced heart failure
Presentation
Mortality predictors and prognostic implications of intermittent levosimendan therapy in advanced heart failure
Cardiac cachexia as a key determinant of clinical stability in advanced heart failure patients treated with intermittent levosimendan
Presentation
Cardiac cachexia as a key determinant of clinical stability in advanced heart failure patients treated with intermittent levosimendan
Clinical predictors of all-cause mortality and heart failure readmissions after intermittent levosimendan
Presentation
Clinical predictors of all-cause mortality and heart failure readmissions after intermittent levosimendan
Pulmonary Embolism in anticoagulated patients: a retrospective single-centered cohort comparing data from the PIOPED II study
Presentation
Pulmonary Embolism in anticoagulated patients: a retrospective single-centered cohort comparing data from the PIOPED II study
Anticoagulants and pulmonary embolism: the surprising impact of apixaban on bilateral embolism
Presentation
Anticoagulants and pulmonary embolism: the surprising impact of apixaban on bilateral embolism
Unmasking myocardial fibrosis by cardiac MRI in patients with frequent ventricular extrasystoles and normal echocardiography
Presentation
Unmasking myocardial fibrosis by cardiac MRI in patients with frequent ventricular extrasystoles and normal echocardiography
Redefining prognostic markers in infective endocarditis: the role of systemic inflammation and anemia
Presentation
Redefining prognostic markers in infective endocarditis: the role of systemic inflammation and anemia
Reassessing surgical risk models in infective endocarditis: are they still valid beyond surgery?
Presentation
Reassessing surgical risk models in infective endocarditis: are they still valid beyond surgery?

ESC 365 is supported by